Browsing publications by Dr Jane Armstrong

Newcastle AuthorsTitleYear
Dr Caroline Bridgens
Dr Gareth Veal
Dr Christopher Redfern
Dr Jane Armstrong
Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold2012
Dr Robert Ellis
Dr Jane Armstrong
Dr Nigel Kirkham
Dr Penny Lovat
p62 as a biomarker of malignant melanoma2012
Raymond Ellis
Dr Jane Armstrong
Dr Nigel Kirkham
Dr Penny Lovat
p62: a novel diagnostic and prognostic biomarker of malignant melanoma2012
Dr Caroline Bridgens
Dr Gareth Veal
Dr Christopher Redfern
Dr Jane Armstrong
Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates2012
Dr Jane Armstrong
Shaun Martin
Nicola Illingworth
Dr David Jamieson
Dr Penny Lovat
et al.		The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide2012
Dr Jane Armstrong
Dr Robert Ellis
Dr Nigel Kirkham
Dr Penny Lovat
WIPI-1: a novel autophagy inhibitory protein in melanoma2012
Dr Robert Ellis
Dr Jane Armstrong
Christopher McKee
Dr Nigel Kirkham
Dr Penny Lovat
et al.		Biomarkers of defective autophagy in melanoma2011
Dr Jane Armstrong
Dr Rob Ellis
Dr Nigel Kirkham
Dr Penny Lovat
Defective autophagy in melanoma development and progression: role of oncogenic B-RAF signalling2011
Dr Jane Armstrong
Shaun Martin
David Hill
Nicola Ellis
Dr Christopher Redfern
et al.		Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition2011
Dr Jane Armstrong
Dr Penny Lovat
Role of defective autophagy in melanoma development and progression: implication of oncogenic B-RAF signalling2011
1234